极早产儿伴新生儿感染时儿童颊部表观遗传年龄加速与不良新生儿脑生长及神经发育结局的关联
这项前瞻性队列研究在加拿大安大略省多伦多2所医院的2个新生儿重症监护病房纳入35例极早产儿(胎龄24-32周),均至少有1次感染,于2017至2018年招募,在早期(中位经后年龄32.9周)和足月矫正胎龄(中位经后年龄43.0周)两个时间点采集颊拭子并做神经影像,2019至2020年完成18个月神经发育评估。极早产儿(<28周)相比胎龄较晚者PedBE年龄加速(β=9.0;95%CI 2.7-15.3;P=.01)。PedBE年龄加速与更小脑容积(β=-5356.8;95%CI -6899.3至-2961.7;P=.01)和更慢脑生长(β=-2651.5;95%CI -5301.2至-1164.1;P=.04)相关,校正临床新生儿因素后仍显著,且仅在足月矫正胎龄时显著。足月矫正胎龄时PedBE年龄加速还与18个月认知(β=-0.4;95%CI -0.8至-0.03;P=.04)和语言(β=-0.6;95%CI -1.1至-0.06;P=.02)评分更低相关。
要点
- 极早产儿(<28周)相比胎龄较晚的极早产儿PedBE年龄加速更明显(β=9.0;95%CI 2.7-15.3;P=.01)。
- 足月矫正胎龄时PedBE年龄加速与更小脑容积(β=-5356.8;95%CI -6899.3至-2961.7;P=.01)和更慢脑生长(β=-2651.5;95%CI -5301.2至-1164.1;P=.04)相关,校正临床因素后仍显著。
- 上述脑生长关联仅在足月矫正胎龄时显著,早期生活阶段未达显著。
- 足月矫正胎龄时PedBE年龄加速与18个月认知评分(β=-0.4;95%CI -0.8至-0.03;P=.04)和语言评分(β=-0.6;95%CI -1.1至-0.06;P=.02)更低相关。
- 作者认为表观遗传衰老与不良新生儿脑健康之间的关联值得进一步关注。
适用人群与场景
- 胎龄24-32周的极早产儿,来自加拿大安大略省多伦多2所医院的2个新生儿重症监护病房,2017至2018年招募。
- 所有新生儿至少有1次感染,因原队列旨在评估新生儿感染与神经发育的关联。
- 排除先天性畸形、遗传综合征或先天性TORCH(弓形虫病、风疹、巨细胞病毒、疱疹及其他病原体)感染的新生儿。
研究设计与关键结果
- 研究类型:前瞻性队列研究。
- 样本量:35例极早产儿(21例男孩[60.0%];中位胎龄27.0周[IQR 25.9-29.9周];23例[65.7%]为极早产[<28周])。
- PedBE年龄通过94个年龄信息性CpG位点的DNA甲基化计算;PedBE年龄差(周)为相应经后年龄减去各时间点PedBE年龄。
- 暴露:早产程度(出生胎龄)和PedBE年龄差;主要结局:新生儿重症监护期间总脑容积和脑生长(2个时间点MRI:生后约前2周和足月矫正胎龄),以及18个月Bayley婴幼儿发育量表第三版神经发育结局。
- 极早产儿(<28周)相比胎龄较晚者PedBE年龄加速(β=9.0;95%CI 2.7-15.3;P=.01)。
- PedBE年龄加速与更小脑容积(β=-5356.8;95%CI -6899.3至-2961.7;P=.01)和更慢脑生长(β=-2651.5;95%CI -5301.2至-1164.1;P=.04)相关,校正临床新生儿因素后仍显著;这些发现在足月矫正胎龄时显著,早期生活阶段不显著。
- 足月矫正胎龄时PedBE年龄加速与18个月认知评分(β=-0.4;95%CI -0.8至-0.03;P=.04)和语言评分(β=-0.6;95%CI -1.1至-0.06;P=.02)更低相关。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
对床旁实践的改变
- 作者认为生物学衰老可能与脑生长受损和神经发育结局相关。
- 作者认为表观遗传衰老与不良新生儿脑健康之间的关联值得进一步关注。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Very preterm neonates (24-32 weeks' gestation) remain at a higher risk of morbidity and neurodevelopmental adversity throughout their lifespan. Because the extent of prematurity alone does not fully explain the risk of adverse neonatal brain growth or neurodevelopmental outcomes, there is a need for neonatal biomarkers to help estimate these risks in this population.
OBJECTIVES: To characterize the pediatric buccal epigenetic (PedBE) clock-a recently developed tool to measure biological aging-among very preterm neonates and to assess its association with the extent of prematurity, neonatal comorbidities, neonatal brain growth, and neurodevelopmental outcomes at 18 months of age.
DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study was conducted in 2 neonatal intensive care units of 2 hospitals in Toronto, Ontario, Canada. A total of 35 very preterm neonates (24-32 weeks' gestation) were recruited in 2017 and 2018, and neuroimaging was performed and buccal swab samples were acquired at 2 time points: the first in early life (median postmenstrual age, 32.9 weeks [IQR, 32.0-35.0 weeks]) and the second at term-equivalent age (TEA) at a median postmenstrual age of 43.0 weeks (IQR, 41.0-46.0 weeks). Follow-ups for neurodevelopmental assessments were completed in 2019 and 2020. All neonates in this cohort had at least 1 infection because they were originally enrolled to assess the association of neonatal infection with neurodevelopment. Neonates with congenital malformations, genetic syndromes, or congenital TORCH (toxoplasmosis, rubella, cytomegalovirus, herpes and other agents) infection were excluded.
EXPOSURES: The extent of prematurity was measured by gestational age at birth and PedBE age difference. PedBE age was computed using DNA methylation obtained from 94 age-informative CpG (cytosine-phosphate-guanosine) sites. PedBE age difference (weeks) was calculated by subtracting PedBE age at each time point from the corresponding postmenstrual age.
MAIN OUTCOMES AND MEASURES: Total cerebral volumes and cerebral growth during the neonatal intensive care unit period were obtained from magnetic resonance imaging scans at 2 time points: approximately the first 2 weeks of life and at TEA. Bayley Scales of Infant and Toddler Development, Third Edition, were used to assess neurodevelopmental outcomes at 18 months.
RESULTS: Among 35 very preterm neonates (21 boys [60.0%]; median gestational age, 27.0 weeks [IQR, 25.9-29.9 weeks]; 23 [65.7%] born extremely preterm [<28 weeks' gestation]), extremely preterm neonates had an accelerated PedBE age compared with neonates born at a later gestational age (β = 9.0; 95% CI, 2.7-15.3; P = .01). An accelerated PedBE age was also associated with smaller cerebral volumes (β = -5356.8; 95% CI, -6899.3 to -2961.7; P = .01) and slower cerebral growth (β = -2651.5; 95% CI, -5301.2 to -1164.1; P = .04); these associations remained significant after adjusting for clinical neonatal factors. These findings were significant at TEA but not earlier in life. Similarly, an accelerated PedBE age at TEA was associated with lower cognitive (β = -0.4; 95% CI, -0.8 to -0.03; P = .04) and language (β = -0.6; 95% CI, -1.1 to -0.06; P = .02) scores at 18 months.
CONCLUSIONS AND RELEVANCE: This cohort study of very preterm neonates suggests that biological aging may be associated with impaired brain growth and neurodevelopmental outcomes. The associations between epigenetic aging and adverse neonatal brain health warrant further attention.
参考来源
- Gomaa N, Konwar C, Gladish N, et al. Association of Pediatric Buccal Epigenetic Age Acceleration With Adverse Neonatal Brain Growth and Neurodevelopmental Outcomes Among Children Born Very Preterm With a Neonatal Infection. JAMA Netw Open. 2022. PMID: 36322087. doi:10.1001/jamanetworkopen.2022.39796
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。